Clinicient Grabs $15M in Series C Financing from Catalyst Investors
March 05, 2014
Clinicient, a provider of revenue cycle management software and clinical solutions for outpatient rehabilitation therapy businesses, has received $15 million in Series C funding from Catalyst Investors. The company serves businesses that have minimal technology and operational resources, enabling workflow efficiencies that result in revenue optimization and business productivity. As part of the investment, Catalyst's Todd Clapp and Ryan McNally have joined Clinicient's Board of Directors.
Clinicient, which is also backed by investors including Capybara Ventures, Village Ventures and Northwest Technology Ventures, among others, has completed a number of VC financings since its founding in 2004, including a previous $1 million Series B1 round that valued the company at more than $8 million in 2012. The company will use the new capital to expand its platform.